MAPT and tauopathy: Several pre-clinical TBI studies have shown increased tau phosphorylation in mouse models of tauopathy at acute and subacute time points [18,19] Many others showed evidence of gliosis and white matter degeneration, which recapitulate key CTE features [20,21,22].